A detailed history of Israel Englander (Millennium Management LLC) transactions in Mannkind Corp stock. As of the latest transaction made, Millennium Management LLC holds 1,650,950 shares of MNKD stock, worth $11.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,650,950
Previous 4,744,519 65.2%
Holding current value
$11.4 Million
Previous $24.8 Million 58.14%
% of portfolio
0.01%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$5.01 - $6.7 $15.5 Million - $20.7 Million
-3,093,569 Reduced 65.2%
1,650,950 $10.4 Million
Q2 2024

Aug 14, 2024

BUY
$4.05 - $5.43 $12.6 Million - $16.9 Million
3,107,598 Added 189.84%
4,744,519 $24.8 Million
Q1 2024

May 15, 2024

BUY
$3.25 - $5.27 $2.45 Million - $3.97 Million
752,916 Added 85.17%
1,636,921 $7.42 Million
Q4 2023

Feb 14, 2024

SELL
$3.34 - $4.29 $2.61 Million - $3.36 Million
-782,864 Reduced 46.97%
884,005 $3.22 Million
Q2 2023

Aug 14, 2023

SELL
$3.72 - $4.79 $8.62 Million - $11.1 Million
-2,317,813 Reduced 58.17%
1,666,869 $6.78 Million
Q1 2023

May 15, 2023

SELL
$3.95 - $5.63 $8.95 Million - $12.8 Million
-2,265,257 Reduced 36.24%
3,984,682 $16.3 Million
Q4 2022

Feb 14, 2023

BUY
$3.02 - $5.37 $11.2 Million - $19.8 Million
3,695,224 Added 144.64%
6,249,939 $32.9 Million
Q3 2022

Nov 14, 2022

BUY
$2.99 - $4.35 $4.05 Million - $5.89 Million
1,354,513 Added 112.86%
2,554,715 $7.89 Million
Q2 2022

Aug 15, 2022

BUY
$2.67 - $4.77 $2.76 Million - $4.93 Million
1,033,915 Added 621.77%
1,200,202 $4.57 Million
Q1 2022

May 16, 2022

SELL
$2.62 - $4.45 $2.76 Million - $4.68 Million
-1,052,649 Reduced 86.36%
166,287 $612,000
Q4 2021

Feb 14, 2022

SELL
$4.05 - $5.37 $6.07 Million - $8.04 Million
-1,498,083 Reduced 55.14%
1,218,936 $5.33 Million
Q3 2021

Nov 15, 2021

BUY
$3.89 - $5.48 $880,050 - $1.24 Million
226,234 Added 9.08%
2,717,019 $11.8 Million
Q2 2021

Aug 16, 2021

SELL
$3.61 - $5.45 $1.4 Million - $2.11 Million
-386,902 Reduced 13.44%
2,490,785 $13.6 Million
Q1 2021

May 17, 2021

BUY
$3.14 - $6.14 $2.53 Million - $4.95 Million
806,828 Added 38.96%
2,877,687 $11.3 Million
Q4 2020

Feb 16, 2021

BUY
$1.79 - $4.04 $3.71 Million - $8.37 Million
2,070,859 New
2,070,859 $6.48 Million
Q3 2020

Nov 16, 2020

SELL
$1.56 - $2.08 $4.34 Million - $5.78 Million
-2,780,026 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$0.94 - $2.21 $1.95 Million - $4.6 Million
2,079,719 Added 296.97%
2,780,026 $4.87 Million
Q1 2020

May 14, 2020

BUY
$0.84 - $1.76 $577,293 - $1.21 Million
687,254 Added 5265.1%
700,307 $721,000
Q4 2019

Feb 14, 2020

SELL
$1.14 - $1.49 $670 - $876
-588 Reduced 4.31%
13,053 $17,000
Q3 2019

Nov 14, 2019

SELL
$1.04 - $1.44 $1.1 Million - $1.52 Million
-1,057,426 Reduced 98.73%
13,641 $17,000
Q2 2019

Aug 15, 2019

SELL
$1.09 - $1.88 $596,340 - $1.03 Million
-547,101 Reduced 33.81%
1,071,067 $1.23 Million
Q1 2019

May 14, 2019

BUY
$1.14 - $2.25 $1.84 Million - $3.64 Million
1,618,168 New
1,618,168 $3.19 Million
Q4 2018

Feb 14, 2019

SELL
$1.02 - $2.05 $93,461 - $187,839
-91,629 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$1.01 - $2.19 $79,404 - $172,173
-78,618 Reduced 46.18%
91,629 $168,000
Q2 2018

Aug 14, 2018

SELL
$1.59 - $2.38 $1.38 Million - $2.07 Million
-869,449 Reduced 83.63%
170,247 $323,000
Q1 2018

May 15, 2018

BUY
$2.28 - $3.8 $2 Million - $3.34 Million
878,432 Added 544.72%
1,039,696 $2.37 Million
Q4 2017

Feb 14, 2018

SELL
$2.28 - $6.71 $1.17 Million - $3.44 Million
-512,779 Reduced 76.08%
161,264 $374,000
Q3 2017

Nov 14, 2017

BUY
$1.15 - $2.29 $775,149 - $1.54 Million
674,043
674,043 $1.46 Million

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.77B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.